HPV: Symptoms, Screening & Cancer Risk | Portugal Health Update

Human papillomavirus (HPV) is a remarkably common sexually transmitted infection, and while most infections resolve on their own within one to two years, some can lead to genital diseases and, in both men and women, certain cancers. Regular screening is a vital step in protecting your health. #Health #HPV

Understanding HPV and its Spread

HPV isn’t a new concern. The link between cervical cancer and sexual behavior was suspected over a century ago, with epidemiological studies in the 1960s beginning to solidify the connection. It wasn’t until the 1980s that HPV DNA was actually identified within cervical cancer cells, and the 1990s saw consistent evidence establishing HPV as a causative agent. Today, we know that HPV consists of a family of over 200 distinct types of DNA viruses that infect the epithelium – the cells lining the skin and mucous membranes. Most types cause common skin warts, but around 40 types infect the mucosal epithelium, and these are the ones most often associated with cancer.

The ease with which HPV is transmitted is a key factor in its prevalence. It’s typically spread through skin-to-skin contact, most often during sexual activity, including vaginal, anal, and oral sex. However, it’s critical to understand that even without visible symptoms, HPV can still be transmitted. The vast majority of people will be infected with HPV at some point in their lives, but, thankfully, most infections are cleared by the body’s immune system without causing any noticeable health problems.

The Link to Cancer: Cervical Cancer and Beyond

While many HPV infections are harmless, persistent infections with high-risk HPV types can lead to serious health consequences. Cervical cancer is the most well-known HPV-related disease, with approximately 99.7% of cases attributed to long-lasting infection with high-risk HPV types. According to the National Center for Biotechnology Information, worldwide, cervical cancer remains one of the most common cancers affecting women, with an estimated 528,000 new cases reported in 2012.

However, the impact of HPV extends beyond cervical cancer. Persistent infection with oncogenic (cancer-causing) HPV types can too contribute to cancers of the oropharynx (back of the throat, including the base of the tongue and tonsils) and anogenital regions, affecting both men and women. The virus disrupts normal cell-cycle control, leading to uncontrolled cell division and the accumulation of genetic damage that can ultimately result in cancer.

HPV Testing and Screening

Fortunately, You’ll see ways to detect and prevent HPV-related cancers. Doctors can test for high-risk HPV types by looking for pieces of their DNA in cervical cells. This represents often done as part of a Pap test, or as a separate HPV test. The American Cancer Society provides guidelines for cervical cancer screening, recommending regular check-ups for individuals with a cervix to help detect cell changes early, before they develop into cancer.

It’s important to note that a positive HPV test result doesn’t necessarily mean you have or will develop cancer. It simply indicates the presence of the virus. Further testing and monitoring may be recommended to determine if the infection is persistent and if there are any signs of cell changes.

The Power of Vaccination

One of the most significant advancements in HPV prevention is the development of vaccines. Currently, there are three HPV vaccines available: a quadrivalent vaccine (protecting against types 6, 11, 16, and 18), a bivalent vaccine (types 16 and 18), and a 9-valent vaccine (types 6, 11, 16, 18, 31, 33, 45, 52, and 58). These vaccines are highly effective in preventing infection with the HPV types they target, and reducing the risk of HPV-related cancers and genital warts.

The CDC’s Pink Book highlights that these vaccines perform by stimulating the body to produce antibodies that fight off HPV infection. While the vaccines are most effective when administered before the start of sexual activity, they can still provide some benefit to individuals who have already been exposed to HPV.

What to Do Next: Staying Informed and Proactive

Given the widespread nature of HPV and its potential health consequences, staying informed and proactive is crucial. Talk to your healthcare provider about your individual risk factors and whether HPV testing or vaccination is right for you. Regular screening, particularly for cervical cancer, remains a cornerstone of prevention.

Public health surveillance continues to play a vital role in monitoring HPV trends and evaluating the effectiveness of vaccination programs. As new research emerges and our understanding of HPV evolves, guidelines and recommendations may be updated. It’s important to stay abreast of the latest information from reputable sources like the CDC, the American Cancer Society, and your healthcare provider.